Lipid Metabolism, glycerophosphoryl diester phosphodiesterase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: A4I3T9
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0006644 | phospholipid metabolic process | 4 | 1 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009395 | phospholipid catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016042 | lipid catabolic process | 4 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044242 | cellular lipid catabolic process | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0046434 | organophosphate catabolic process | 4 | 1 |
GO:0046475 | glycerophospholipid catabolic process | 6 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0046503 | glycerolipid catabolic process | 5 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008081 | phosphoric diester hydrolase activity | 5 | 11 |
GO:0008889 | glycerophosphodiester phosphodiesterase activity | 6 | 5 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 141 | 145 | PF00656 | 0.435 |
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.472 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.295 |
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.273 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.286 |
CLV_PCSK_KEX2_1 | 339 | 341 | PF00082 | 0.529 |
CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.310 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.302 |
CLV_PCSK_PC1ET2_1 | 339 | 341 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.297 |
CLV_PCSK_SKI1_1 | 232 | 236 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 32 | 36 | PF00082 | 0.336 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.316 |
DEG_SPOP_SBC_1 | 260 | 264 | PF00917 | 0.329 |
DOC_CYCLIN_RxL_1 | 27 | 36 | PF00134 | 0.436 |
DOC_MAPK_FxFP_2 | 39 | 42 | PF00069 | 0.545 |
DOC_MAPK_gen_1 | 125 | 132 | PF00069 | 0.443 |
DOC_MAPK_gen_1 | 162 | 169 | PF00069 | 0.418 |
DOC_MAPK_gen_1 | 339 | 348 | PF00069 | 0.282 |
DOC_MAPK_gen_1 | 80 | 89 | PF00069 | 0.504 |
DOC_MAPK_MEF2A_6 | 125 | 132 | PF00069 | 0.510 |
DOC_MAPK_MEF2A_6 | 162 | 171 | PF00069 | 0.468 |
DOC_MAPK_MEF2A_6 | 178 | 187 | PF00069 | 0.384 |
DOC_MAPK_MEF2A_6 | 339 | 348 | PF00069 | 0.356 |
DOC_MAPK_NFAT4_5 | 125 | 133 | PF00069 | 0.510 |
DOC_MAPK_RevD_3 | 15 | 30 | PF00069 | 0.388 |
DOC_PP4_FxxP_1 | 228 | 231 | PF00568 | 0.473 |
DOC_PP4_FxxP_1 | 256 | 259 | PF00568 | 0.251 |
DOC_PP4_FxxP_1 | 285 | 288 | PF00568 | 0.335 |
DOC_PP4_FxxP_1 | 39 | 42 | PF00568 | 0.545 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.430 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.511 |
DOC_USP7_UBL2_3 | 115 | 119 | PF12436 | 0.565 |
DOC_USP7_UBL2_3 | 174 | 178 | PF12436 | 0.507 |
DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.282 |
LIG_APCC_ABBA_1 | 167 | 172 | PF00400 | 0.429 |
LIG_BRCT_BRCA1_1 | 176 | 180 | PF00533 | 0.477 |
LIG_BRCT_BRCA1_1 | 194 | 198 | PF00533 | 0.422 |
LIG_CaM_IQ_9 | 19 | 34 | PF13499 | 0.471 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.501 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.439 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.451 |
LIG_FHA_1 | 235 | 241 | PF00498 | 0.414 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.450 |
LIG_LIR_Apic_2 | 254 | 259 | PF02991 | 0.246 |
LIG_LIR_Apic_2 | 36 | 42 | PF02991 | 0.400 |
LIG_LIR_Gen_1 | 177 | 188 | PF02991 | 0.570 |
LIG_LIR_Gen_1 | 237 | 246 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 250 | 261 | PF02991 | 0.235 |
LIG_LIR_Gen_1 | 59 | 69 | PF02991 | 0.453 |
LIG_LIR_LC3C_4 | 109 | 113 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.194 |
LIG_LIR_Nem_3 | 272 | 276 | PF02991 | 0.372 |
LIG_LYPXL_SIV_4 | 13 | 21 | PF13949 | 0.171 |
LIG_PCNA_yPIPBox_3 | 317 | 330 | PF02747 | 0.290 |
LIG_PTB_Apo_2 | 208 | 215 | PF02174 | 0.489 |
LIG_SH2_CRK | 103 | 107 | PF00017 | 0.499 |
LIG_SH2_CRK | 242 | 246 | PF00017 | 0.376 |
LIG_SH2_CRK | 273 | 277 | PF00017 | 0.308 |
LIG_SH2_PTP2 | 14 | 17 | PF00017 | 0.285 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.249 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.496 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.256 |
LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.464 |
LIG_SH3_1 | 162 | 168 | PF00018 | 0.435 |
LIG_SH3_3 | 162 | 168 | PF00018 | 0.416 |
LIG_SUMO_SIM_anti_2 | 179 | 185 | PF11976 | 0.426 |
LIG_SUMO_SIM_anti_2 | 308 | 314 | PF11976 | 0.372 |
LIG_SUMO_SIM_par_1 | 126 | 131 | PF11976 | 0.470 |
LIG_SUMO_SIM_par_1 | 5 | 10 | PF11976 | 0.345 |
LIG_SUMO_SIM_par_1 | 73 | 78 | PF11976 | 0.429 |
LIG_TYR_ITIM | 240 | 245 | PF00017 | 0.352 |
LIG_TYR_ITIM | 246 | 251 | PF00017 | 0.434 |
LIG_UBA3_1 | 21 | 29 | PF00899 | 0.333 |
LIG_WRC_WIRS_1 | 60 | 65 | PF05994 | 0.464 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.472 |
MOD_CK2_1 | 30 | 36 | PF00069 | 0.457 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.277 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.481 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.613 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.482 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.472 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.414 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.388 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.365 |
MOD_NEK2_1 | 283 | 288 | PF00069 | 0.355 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.450 |
MOD_NEK2_2 | 56 | 61 | PF00069 | 0.408 |
MOD_PK_1 | 2 | 8 | PF00069 | 0.166 |
MOD_PKA_1 | 37 | 43 | PF00069 | 0.562 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.520 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.464 |
MOD_Plk_1 | 149 | 155 | PF00069 | 0.445 |
MOD_Plk_1 | 56 | 62 | PF00069 | 0.408 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.445 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.290 |
MOD_Plk_4 | 234 | 240 | PF00069 | 0.411 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.584 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.389 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.399 |
MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.278 |
MOD_SUMO_for_1 | 173 | 176 | PF00179 | 0.455 |
MOD_SUMO_rev_2 | 172 | 180 | PF00179 | 0.510 |
MOD_SUMO_rev_2 | 33 | 40 | PF00179 | 0.451 |
TRG_DiLeu_BaEn_2 | 175 | 181 | PF01217 | 0.544 |
TRG_DiLeu_BaEn_2 | 193 | 199 | PF01217 | 0.372 |
TRG_DiLeu_BaLyEn_6 | 285 | 290 | PF01217 | 0.301 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.352 |
TRG_ENDOCYTIC_2 | 225 | 228 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 238 | 241 | PF00928 | 0.266 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.254 |
TRG_ENDOCYTIC_2 | 248 | 251 | PF00928 | 0.388 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.266 |
TRG_ENDOCYTIC_2 | 273 | 276 | PF00928 | 0.197 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.470 |
TRG_ER_diArg_1 | 221 | 224 | PF00400 | 0.503 |
TRG_NLS_MonoExtC_3 | 221 | 226 | PF00514 | 0.516 |
TRG_NLS_MonoExtN_4 | 219 | 226 | PF00514 | 0.557 |
TRG_NLS_MonoExtN_4 | 27 | 33 | PF00514 | 0.642 |
TRG_Pf-PMV_PEXEL_1 | 135 | 139 | PF00026 | 0.227 |
TRG_Pf-PMV_PEXEL_1 | 32 | 36 | PF00026 | 0.217 |
TRG_Pf-PMV_PEXEL_1 | 332 | 336 | PF00026 | 0.416 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8E4 | Leptomonas seymouri | 56% | 99% |
A0A0S4IJ80 | Bodo saltans | 35% | 85% |
A0A1X0NRF0 | Trypanosomatidae | 46% | 98% |
A0A3R7NHN9 | Trypanosoma rangeli | 44% | 99% |
A0A3S7X1Q6 | Leishmania donovani | 99% | 100% |
A4HGR4 | Leishmania braziliensis | 79% | 100% |
D0A869 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9B031 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q0VGK4 | Rattus norvegicus | 28% | 100% |
Q4Q855 | Leishmania major | 91% | 100% |
Q7L5L3 | Homo sapiens | 27% | 100% |
Q8N9F7 | Homo sapiens | 29% | 100% |
Q99LY2 | Mus musculus | 26% | 100% |
Q9CRY7 | Mus musculus | 28% | 100% |